Europe (WHO region) vs Mauritania: Previously treated cases tested for RR-/MDR-TB
Europe (WHO region)
90.0%
in 2024
Mauritania
100.0%
in 2023
Europe (WHO region) rank
2nd
Mauritania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Mauritania
How they compare
Mauritania currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Mauritania's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 2 times across 13 shared years of data; in 2005 it was Mauritania ahead.
Europe (WHO region) ranks 2nd and Mauritania ranks 1st of 11 groups.
Across the 3 decades both report, Europe (WHO region) averaged higher in 2 and Mauritania in 1.
Head to head by decade
| Decade | Europe (WHO region) | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.7% | 7.5% | 7.2% | Europe (WHO region) |
| 2010s | 66.5% | 44.7% | 21.8% | Europe (WHO region) |
| 2020s | 94.8% | 100.0% | 5.2% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Europe (WHO region) or Mauritania?
- Mauritania, at 100.0% against 90.0% in Europe (WHO region) as of 2023.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Europe (WHO region) and Mauritania?
- 10.0%, with Mauritania ahead.
- How many years of comparable data are there for Europe (WHO region) and Mauritania?
- 13 years are reported by both, from 2005 to 2023.
- How do Europe (WHO region) and Mauritania rank globally for previously treated cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 2nd and Mauritania ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.